Cognitive Support & Brain Protection Protocol

A physician-supervised approach to restoring mental clarity and protecting long-term brain health — addressing the upstream drivers of brain fog and cognitive decline at the cellular level.

At a Glance

What it targets: The upstream drivers of brain fog and cognitive decline — neuroinflammation, impaired neuroplasticity, cellular energy deficits, and the systemic factors that affect brain function.

Who it’s for: Adults 35-60 with mental sluggishness, memory lapses, word-finding difficulty, post-COVID cognitive symptoms, or those wanting to act on family history of cognitive decline before symptoms emerge.

How it works: An IV foundation, then physician-selected neuropeptides as options based on your clinical picture — BDNF support, anxiolytic-cognitive, gene-expression modulation, or synaptogenesis — layered with diagnostics and the lifestyle structure that protects long-term brain health.

What to expect: Initial improvements in focus and clarity in the early phase. Meaningful cognitive gains and neuroplastic changes build across the sustained phase.

Who This Protocol Is For

ALIV’s Cognitive Support Protocol is for adults who feel their brain isn’t performing the way it used to. Many clients arrive specifically researching brain fog treatment, memory loss treatment, concentration improvement, post-COVID brain fog, or Alzheimer’s/dementia prevention in India — and want a physician-led integrative approach rather than generic nootropics. A notable proportion of people who recovered from COVID-19 (estimated 22-32% in published cohorts) experience persistent brain fog, and Indian cohort data shows neurological symptoms can persist years after acute infection.

This protocol was built for you if:

• Words that used to come easily now take a moment to find
• Concentration through a full workday has become harder — you need breaks you never used to need
• Memory feels noticeably less sharp than it was 5-10 years ago
• Brain fog is worse after meals, poor sleep, or high-stress weeks
• Family history of Alzheimer’s or cognitive decline — you want to act before symptoms appear

The important reframe: brain fog is rarely a brain problem in isolation. It’s almost always a thyroid problem, an insulin problem, an inflammation problem, or a sleep problem expressing itself through the brain. Effective cognitive support starts with finding the actual driver.

How It Works — The ALIV Approach

This protocol combines neuropeptides that directly support brain function with diagnostics and interventions targeting the upstream drivers of cognitive symptoms. The peptide layers below are tools your physician selects from based on your clinical picture; not every layer is appropriate for every client.

Layer 1 — IV Foundation

This protocol typically opens with an IV foundation. ALIV’s Myer’s Cocktail delivers a clinically-established blend of vitamins (B-complex, B12, vitamin C) and minerals (magnesium, calcium) at bioavailability oral supplementation cannot reach. An introductory course of NAD+ Vitality IV supports the mitochondrial energy production the brain depends on heavily — neurons have among the highest energy demands of any tissue.

Layer 2 — Neuropeptide Options

Several neuropeptides target distinct mechanisms in cognitive function. These exist as options requiring physician selection — not as a default stack, but as tools chosen based on what your clinical picture is most strongly driven by.

Semax — a synthetic ACTH(4-10) analog with decades of clinical use in Russia for stroke recovery and cognitive disorders. It upregulates BDNF (brain-derived neurotrophic factor), the molecule that supports neuron survival and neuroplasticity. Best fit when the dominant picture is mental sluggishness or post-viral cognitive symptoms.

Selank — a synthetic tuftsin analog that modulates the GABAergic system and HPA axis, producing anxiolytic effects without the sedation or dependence risk of benzodiazepines. Best fit when stress and anxiety are major contributors to the brain fog.

GHK-Cu — a naturally-occurring copper-binding peptide that modulates expression of thousands of genes, with documented effects on antioxidant defence and neuroprotective pathways. Best fit when broad neuroprotective and anti-inflammatory support is the goal.

Layer 3 — Diagnostic Precision

Before any peptide protocol, your ALIV physician runs a comprehensive cognitive workup. Standard reports often miss what matters: thyroid function with antibodies, fasting insulin and HbA1c, full nutrient status (B12, methylated folate, D, iron, magnesium), inflammatory markers, hormonal profile, sleep architecture screening. The protocol layers reflect your specific drivers — not every layer is appropriate for every client.

What to Expect

Most clients on this protocol notice initial improvements in focus and mental clarity in the early phase, with deeper cognitive gains and neuroplastic changes emerging across the sustained phase. Cognitive change is gradual; the brain rebuilds over weeks and months, not days.

Individual outcomes vary based on baseline cognitive state, age, underlying drivers, and adherence to the lifestyle layer. ALIV does not guarantee specific outcomes.

What’s Involved

Before starting, your ALIV medical team runs the cognitive-focused diagnostic workup described above and designs a protocol specifically for you. Contraindications detailed in the FAQ below.

The Lifestyle Layer

Peptides and IV therapy create the biological opening. The lifestyle layer consolidates and protects results long-term.

Sleep — The Foundation

The brain clears Alzheimer’s-related proteins (beta-amyloid, tau) during deep sleep through the glymphatic system. Chronic poor sleep accelerates cognitive ageing. Where sleep is meaningfully disrupted, coordination with ALIV’s Sleep Protocol is part of the design.

Targeted Supplementation

Supplementation is tailored to your assessment. Common compounds include Omega-3 (DHA-dominant) for membrane phospholipid support, Magnesium L-threonate specifically for brain bioavailability, Methylated B-vitamins where MTHFR variants are present, Vitamin D, CoQ10 (ubiquinol), and NMN or NR as oral NAD+ precursors after the IV foundation phase.

Movement That Builds Brain

Regular moderate-intensity aerobic exercise — the kind where you can hold a conversation — stimulates BDNF release and increases hippocampal volume in controlled studies. The single most evidence-supported lifestyle intervention for cognitive protection.

Address the Upstream Drivers

Insulin resistance impairs brain glucose metabolism — the diagnostic layer screens for this. Chronic stress shrinks the hippocampus through cortisol; meditation, breathwork, or any consistent practice helps. Air pollution is a recognised dementia risk factor (per the 2024 Lancet Commission), particularly relevant for Indian urban residents — HEPA air purification at home is worth the investment.

Frequently Asked Questions

Is brain fog actually treatable, or do I just have to live with it?

Brain fog is highly treatable in most cases — but only when the actual underlying cause is identified. Most generic treatments fail because they target symptoms without finding the driver, which is often thyroid, insulin, inflammation, sleep, or nutrient-related. The diagnostic-first approach is the difference.

What causes brain fog?

Brain fog is rarely a primary brain problem — it’s usually another system expressing itself through cognition. Common drivers: suboptimal thyroid function, insulin resistance and glucose dysregulation, chronic systemic inflammation, poor sleep architecture or undiagnosed sleep apnoea, B12/D/iron/magnesium deficiency, hormonal shifts (especially perimenopause), chronic stress, and post-viral inflammation. Brain fog after meals usually points to glucose dysregulation. Diagnostics identify which is driving yours.

Can cognitive decline be reversed?

Depends on cause. Functional cognitive symptoms driven by metabolic, hormonal, inflammatory, or sleep issues are often substantially reversible once the upstream driver is corrected. Established neurodegenerative disease cannot be reversed with any current therapy, but trajectory can be modified. The clearer the upstream driver, the better the potential outcome.

Can this prevent dementia or Alzheimer’s?

No protocol — and no medication currently available globally — can guarantee dementia prevention. What research does support is risk reduction: the 2024 Lancet Commission identified 14 modifiable risk factors accounting for ~45% of dementia cases. This protocol addresses many of them at both diagnostic and intervention levels.

I had long COVID and my cognition never fully recovered. Can this help?

Post-viral cognitive symptoms are a focus of ALIV’s work. Semax in particular has been used in Russian clinical practice for post-stroke and post-viral cognitive deficits. Whether it’s the right fit depends on the diagnostic picture — sometimes the dominant issue is metabolic or inflammatory rather than directly neurological.

Who should NOT do this protocol?

Active malignancy; pregnancy or breastfeeding; untreated significant psychiatric conditions; clients where specialist neurology referral is the more appropriate first step (e.g., progressive deficits suggesting active neurodegenerative disease); those seeking to bypass appropriate medical workup.

Take the Next Step

If your brain isn’t performing the way it used to — or you want to act on cognitive protection before symptoms appear — this protocol may be worth exploring.

To find out if the Cognitive Support Protocol is right for you, speak with our medical team:

• Pune (Bund Garden): +91 77199 88811
• Mumbai (Khar West): +91 98220 93069

Or book a consultation through alivtherapy.in.

Research References

1. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60. PMID: 16996037

2. Volkova A, Shadrina M, Kolomin T, et al. Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Front Pharmacol. 2016;7:31. PMID: 26924987

3. Pickart L, Vasquez-Soltero JM, Margolina A. The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sci. 2017;7(2):20. PMID: 28212278

4. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572-628. DOI: 10.1016/S0140-6736(24)01296-0

5. Conlon NJ. The role of NAD+ in regenerative medicine. Plast Reconstr Surg. 2022;150(4 Suppl):41S-48S. PMID: 36170435

6. Singh AK, Kumar K, Singh M, et al. Neuropsychiatric manifestations of Long COVID in India: a persistent problem 2.5 years after disease onset. Front Neurol. 2025;16:1704801. PMID: 41312347

Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease, including dementia or Alzheimer’s disease. This protocol is integrative supportive care, not a replacement for specialist neurological management where indicated. Outcomes vary significantly between individuals. The neuropeptides referenced (Semax, Selank, GHK-Cu) are not FDA-approved and are accessed in India via compounding pharmacies; physician supervision and informed consent are essential. Please consult a qualified healthcare professional before starting any therapy programme.